menu

The Risk of Lipoprotein(a) in ASCVD

Be part of the knowledge.
Register

We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?

Register for free

The Risk of Lipoprotein(a) in ASCVD

Program Information
Recommended

Program Information

ReachMD Healthcare Image
RestartResume

Join experts as they discuss why it’s important to recognize elevated levels of lipoprotein(a) as an additional cardiovascular risk factor in patients with ASCVD.

  • Overview

    Cardiovascular risk is influenced by several factors. While many clinicians tend to focus on elevated levels of LDL cholesterol and lifestyle factors, it is now recognized that there is an independent, genetically determined risk factor for atherosclerotic cardiovascular disease (ASCVD) called lipoprotein(a), or Lp(a) for short. In this program, Dr. Pam Taub and Dr. Robert Rosenson discuss why it’s important to recognize elevated levels of Lp(a) as an additional cardiovascular risk factor and important contributor to residual risk in patients with ASCVD.

Schedule18 May 2022
Webpack App